Clinical Trial

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Name: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — clinical trial record (NCT07402915)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the effect of itraconazole on the pharmacokinetics (PK) of AZ14170132.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2026-02-04; most recent amendment 2026-07-03.

Trial Details

NCT Number	NCT07402915
Lead Sponsor	AstraZeneca
Conditions	Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal
Enrollment	24 participants
Start Date	2026-01-26
Primary Completion	2027-10-15 (estimated)
Study Completion	2027-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-07